Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Innate neuroimmunity across aging and neurodegeneration: a perspective from amyloidogenic evolvability.
Journal: Frontiers in cell and developmental biology
Published: May 10, 2024
Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease.
Journal: Parkinson's disease
Published: June 04, 2021
Reconsideration of Alzheimer's Disease Therapy from a Viewpoint of Amyloidogenic Evolvability.
Journal: Journal of Alzheimer's disease reports
Published: April 08, 2021
Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: April 05, 2021
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
Journal: Biomolecules
Published: January 14, 2021
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2.
Journal: Drug discovery today
Published: November 16, 2020
Adiponectin paradox as a therapeutic target of the cancer evolvability in aging.
Journal: Neoplasia (New York, N.Y.)
Published: September 16, 2020
Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 06, 2020
Connecting Alzheimer's Disease With Diabetes Mellitus Through Amyloidogenic Evolvability.
Journal: Frontiers in aging neuroscience
Published: June 25, 2020
Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.
Journal: Prion
Published: May 08, 2020
Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
Journal: International journal of molecular sciences
Published: January 19, 2020
Last Updated: 09/26/2026